drugset / Trial / NCT05536596

Pharmacological Treatment on the Recovery of Neurosensory Disturbance After Bilateral Sagittal Split Osteotomy

NCT05536596

RandomizedParallel-groupDouble-blindTreatment

Summary

The bilateral sagittal split osteotomy (BSSO) of the mandible is one of the most used surgical techniques to achieve a harmonious jaw relation in the context of orthognathic surgery. Nevertheless, one of its main complications is neurosensory damage to the inferior alveolar nerve, which can cause severe impact in the quality of life on patients who suffer from it permanently. The purpose of this randomized clinical trial is to provide rigorous scientific evidence of the pharmacological effect of 1) Melatonin, 2) combination uridine triphosphate (UTP), cytidine monophosphate (CMP), and hydroxycobalamin (UTP/CMP/hydroxycobalamin) and 3) hydroxycobalamin regarding neurosensory disturbances incidence and persistence after BSSO.

Timeline

Start
2022-09-30
Primary completion
2024-06-30
Completion
2024-12-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Hydroxocobalamin Unknown 1 mg Oral
Subject Melatonin Small molecule 10 mg Oral
Subject Uridine Triphosphate Unknown 1.5 mg Oral
Subject cytidine monophosphate Unknown 2.5 mg Oral